Improvement of Nephrotoxicity, Hypertension, and Lipid Metabolism After Conversion of Kidney Transplant Recipients From Cyclosporine to Tacrolimus
- 1 June 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (4) , 1240-1242
- https://doi.org/10.1016/s0041-1345(98)00226-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- TacrolimusDrugs, 1993
- Chronic Allograft RejectionImmunological Reviews, 1993
- EARLY VERSUS LATE ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1993
- CyclosporineNew England Journal of Medicine, 1989
- The increasing importance of chronic rejection as a cause of renal allograft failureTransplant International, 1989
- PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506Transplantation, 1988
- Evolution of Liver TransplantationHepatology, 1982